Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M2 | ||
Ligand | BDBM50522832 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888527 (CHEMBL4390204) | ||
Ki | 1.000000±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M2 | |||
Name: | Muscarinic acetylcholine receptor M2 | ||
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 | ||
Type: | GPCR | ||
Mol. Mass.: | 51730.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08172 | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50522832 | |||
n/a | |||
Name | BDBM50522832 | ||
Synonyms: | CHEMBL4483083 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H34BrNO3 | ||
Mol. Mass. | 536.5 | ||
SMILES | [Br-].OC(C(=O)O[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |r,wU:6.4,(82.97,-35.31,;73.57,-37.16,;74.91,-37.93,;76.24,-38.7,;76.25,-40.24,;77.57,-37.92,;78.91,-38.69,;80.24,-37.91,;81.56,-38.69,;82.9,-37.92,;84.23,-38.69,;85.56,-37.93,;86.9,-38.7,;86.89,-40.24,;88.22,-41.01,;89.56,-40.24,;89.56,-38.7,;88.22,-37.93,;81.57,-40.23,;80.24,-40.99,;78.91,-40.23,;80.4,-40.03,;80.05,-38.98,;74.9,-36.39,;76.23,-35.62,;76.23,-34.08,;74.89,-33.31,;73.56,-34.1,;73.57,-35.63,;73.57,-38.7,;72.24,-37.93,;70.91,-38.7,;70.91,-40.25,;72.26,-41.01,;73.58,-40.24,)| | ||
Structure |